AI-generated summary
The authors treated 40 oral verrucous hyperplasia lesions and 40 oral erythroleukoplakia lesions with topical 5-aminolevulinic acid photodynamic therapy using a 635-nm laser. They report complete response in all 40 verrucous lesions and in 38 of 40 erythroleukoplakia lesions, with the remaining two showing partial response. The abstract does not describe a control group.
- Who or what was studied
- Patients with oral verrucous hyperplasia (40 lesions) or oral erythroleukoplakia (40 lesions)
- Wavelengths
- 635 nm
- Limits stated in the abstract
- The abstract does not describe a control group, and the authors do not report long-term follow-up or recurrence data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.